Pre-clinical efficacy assessment of Malva sylvestris on chronic skin inflammation
Preclinical
Abstract
A topical Malva sylvestris preparation reduced chronic skin inflammation in a preclinical model relevant to psoriasis, decreasing inflammatory infiltrate and oedema, supporting the use of common mallow for inflammatory skin conditions.
Referenced for these plants
How to cite
Prudente, A.S., Sponchiado, G., Mendes, D.A.G.B., Soley, B.S. and others (2017) 'Pre-clinical efficacy assessment of Malva sylvestris on chronic skin inflammation', Biomedicine & Pharmacotherapy, 93, pp. 852-860. doi:10.1016/j.biopha.2017.06.083
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.